Multiple sclerosis can affect pediatric patients. Our aim was to compare characteristics between pediatric-onset multiple sclerosis and adult-onset multiple sclerosis in Hispanic Americans. This was a cross-sectional analysis of 363 Hispanic American multiple scleroses cases; demographic and clinical characteristics were analyzed. A total of 110 Hispanic patients presented with multiple sclerosis before age 18 and 253 as adult multiple sclerosis. The most common presenting symptoms for both was optic neuritis. Polyfocal symptoms, seizures, and cognitive symptoms at presentation were more prevalent in pediatric-onset multiple sclerosis (P ≤ .001). Transverse myelitis was more frequent in adult-onset multiple sclerosis (P ≤ .001). Using multivariable analysis, pediatric-onset multiple sclerosis (adjusted odds ratio, 0.3OR 95% confidence interval 0.16-0.71, P = .004) and being US born (adjusted odds ratio, 0.553, 95% confidence interval 0.3-1.03, P = .006) were less likely to have severe ambulatory disability. Results suggest that pediatric-onset multiple sclerosis and adult-onset multiple sclerosis in Hispanics have differences that could be important for treatment and prognosis.
AhlgrenCOdenALyckeJ. High nationwide prevalence of multiple sclerosis in Sweden. Mult Scler. 2011;17:901–908.
2.
BanwellBGhezziABar-OrAMikaeloffYTardieuM. Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol. 2007;6:887–902.
3.
BoikoAVorobeychikGPatyDDevonshireVSadovnickDNeurologistsUMC. Early onset multiple sclerosis—a longitudinal study. Neurology. 2002;59:1006–1010.
4.
ChitnisTGlanzBJaffinSHealyB. Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States. Mult Scler. 2009;15:627–631.
5.
Langer-GouldAZhangJLChungJYeungYWaubantEYaoJ. Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children. Neurology. 2011;77:1143–1148.
6.
AhnJJO’MahonyJMoshkovaM. Puberty in females enhances the risk of an outcome of multiple sclerosis in children and the development of central nervous system autoimmunity in mice. Mult Scler. 2015;21:735–748.
7.
Aubert-BrocheBFonovVNarayananS. Onset of multiple sclerosis before adulthood leads to failure of age-expected brain growth. Neurology. 2014;83:2140–2146.
8.
BrownRANarayananSBanwellBArnoldDL, for the Canadian Pediatric Demyelinating Disease Network. Magnetization transfer ratio recovery in new lesions decreases during adolescence in pediatric-onset multiple sclerosis patients. Neuroimage Clin. 2014;6:237–242.
9.
GhassemiRNarayananSBanwellB. Quantitative determination of regional lesion volume and distribution in children and adults with relapsing-remitting multiple sclerosis. PLos One. 2014;9:e85741.
10.
HanwellHViethRMagalhaesS. Vitamin D status as a predictor of MS outcome following an initial paediatric demyelinating event. Mult Scler. 2009;15:S40–S41.
11.
WaubantEMowryEMKruppL. Common viruses associated with lower pediatric multiple sclerosis risk. Neurology. 2011;76:1989–1995.
12.
Berg-HansenPSmestadCSandvikLHarboHFCeliusEG. Increased disease severity in non-Western immigrants with multiple sclerosis in Oslo, Norway. Eur J Neurol. 2013;20:1546–1552.
13.
AlfredssonLHedstromAKHillertJOlssonT. High body mass index before age 20 is associated with increased risk for MS in both men and women: results from the Epidemiological Investigation of Multiple Sclerosis (EIMS). Mult Scler. 2012;18:317–317.
14.
AmezcuaLContiDVLiuLLedezmaKLanger-GouldAM. Place of birth, age of immigration, and disability in Hispanics with multiple sclerosis. Mult Scler Relat Disord. 2015;4:25–30.
15.
AmezcuaLChungRHContiDVLanger-GouldAM. Vitamin D levels in Hispanics with multiple sclerosis. J Neurol. 2012;259:2565–2570.
16.
DebouverieMLebrunCJeanninSPittion-VouyovitchSRoedererTVespignaniH. More severe disability of North Africans vs Europeans with multiple sclerosis in France. Neurology. 2007;68:29–32.
17.
Langer-GouldABraraSMBeaberBEZhangJL. Incidence of multiple sclerosis in multiple racial and ethnic groups. Neurology. 2013;80:1734–1739.
18.
FragosoYDBrito FerreiraMLOliveira MoralesNdM. Multiple sclerosis starting before the age of 18 years: the Brazilian experience. Arq Neuropsiquiatr. 2013;71:783–787.
19.
AmezcuaLLernerALedezmaK. Spinal cord lesions and disability in Hispanics with multiple sclerosis. J Neurol. 2013;260:2770–2776.
20.
AmezcuaLLundBTWeinerLPIslamT. Multiple sclerosis in Hispanics: a study of clinical disease expression. Mult Scler. 2011;17:1010–1016.
21.
WallinMTCulpepperWJCoffmanP. The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service. Brain. 2012;135:1778–1785.
22.
MowryEMKruppLBMilazzoM. Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol. 2010;67:618–624.
WaldmanAGhezziABar-OrAMikaeloffYTardieuMBanwellB. Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research. Lancet Neurol. 2014;13:936–948.
25.
BelmanAChabasDChitnisT. Clinical spectrum of diagnoses in children referred for evaluation of acquired CNS demyelinating disorders including pediatric multiple sclerosis. Ann Neurol. 2007;62:S115–S115.
26.
Bajer-KornekBBaumhacklUVassK. Epidemiology of paediatric-onset multiple sclerosis in Austria. Mult Scler. 2009;15:S38–S38.
KruppLBTardieuMAmatoMP. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler. 2013;19:1261–1267.
29.
SadakaYVerheyLHShroffMM. 2010 McDonald criteria for diagnosing pediatric multiple sclerosis. Ann Neurol. 2012;72:211–223.
30.
CoronaTRomanGC. Multiple sclerosis in Latin America. Neuroepidemiology. 2006;26:1–3.
31.
CristianoERojasJIRomanoM. Systematic review of multiple sclerosis in Latin America. Mult Scler. 2012;18:1875–1875.
32.
OjedaEDiaz-CortesDRosalesDDuarte-ReyCAnayaJ-MRojas-VillarragaA. Prevalence and clinical features of multiple sclerosis in Latin America. Clin Neurol Neurosurg. 2013;115:381–387.
33.
RiveraVM. Multiple sclerosis in Latin America: reality and challenge. Neuroepidemiology. 2009;32:294–295.
34.
Langer-GouldABraraSMBeaberBEZhangJL. The incidence of clinically isolated syndrome in a multi-ethnic cohort. Neurology. 2014:1349–1355.
35.
Langer-GouldAPopatRAHuangSM. Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review. Arch Neurol. 2006;63:1686–1691.
36.
HadjixenofontosABeechamAHManriqueCP. Clinical expression of multiple sclerosis in Hispanic whites of primarily Caribbean ancestry. Neuroepidemiology. 2015;44:262–268.
37.
KennedyJO’ConnorPSadovinickADPeraraMYeeIBanwellB. Age at onset of multiple sclerosis may be influenced by place of residence during childhood rather than ancestry. Neuroepidemiology. 2006;26:162–167.
38.
DurmusHKurtuncuMTuzunE. Comparative clinical characteristics of early- and adult-onset multiple sclerosis patients with seizures. Acta Neurologica Belgica. 2013;113:421–426.
39.
GormanMPHealyBCPolgar-TurcsanyiMChitnisT. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol. 2009;66:54–59.
40.
RenouxCVukusicSMikaeloffY. Natural history of multiple sclerosis with childhood onset. N Engl J Med. 2007;356:2603–2613.
BoikoAVorobeychikGPatyDDevonshireVSadovnickD. Early onset multiple sclerosis: a longitudinal study. Neurology. 2002;59:1006–1010.
43.
SimoneILCarraraDTortorellaC. Course and prognosis in early-onset MS: comparison with adult-onset forms. Neurology. 2002;59:1922–1928.
44.
LossiusARiiseTPugliattiM. Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study. Mult Scler. 2014;20:669–674.
